USANA Health Sciences, Inc. Investor Relations

Financial Information

Quarter Ended Sep 30, 2023

Latest Financial Results

Q3 2023

Get Alerts

$213M

Third quarter net sales were $213 million

$0.59

Third quarter diluted EPS was $0.59

For complete information regarding our financials, see our periodic filings

View the Latest Financials

Balance

Includes Current Assets, Liabilities and Stockholder's Equity

View Balance Sheet

Income

Includes Total Net Sales, Cost & Expenses and Earnings per share

View Income Statement

Cash

Includes Net Income, Adjustments, and Cash flows from investing & financing activities

View Cash Flow